Global Smoking Cessation & Nicotine De-Addiction Product Market Report 2023-2030: Significant Online Market Presence Coupled with Social and Communal Support Driving New Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Smoking Cessation & Nicotine De-Addiction Product Market by Product, Distribution - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030" report has been added to ResearchAndMarkets.com's offering.

The Global Smoking Cessation & Nicotine De-Addiction Product Market has demonstrated significant growth, with an estimated value of USD 25.85 billion in 2022, reaching USD 28.25 billion in 2023, and projected to expand at a robust Compound Annual Growth Rate (CAGR) of 9.61% to reach an impressive USD 53.87 billion by 2030.

This comprehensive report encompasses historical years from 2018 to 2021, using 2022 as the base year, estimating 2023, and forecasting from 2024 to 2030. The report not only addresses the impact of High Inflation on the global economy but also provides detailed insights into fiscal policies aimed at mitigating its effects on demand, supply, cash flow, and currency exchange.

To assess the Global Smoking Cessation & Nicotine De-Addiction Product Market, the FPNV Positioning Matrix plays a vital role. This matrix evaluates vendors by analyzing key metrics within Business Strategy and Product Satisfaction, empowering users to make well-informed decisions tailored to their specific needs. The advanced analysis categorizes vendors into four distinct quadrants, namely Forefront (F), Pathfinder (P), Niche (N), and Vital (V), representing varying levels of success.

Market Share Analysis delves into the current landscape of vendors within a particular market space. By comparing vendor contributions to overall revenue, customer base, and other essential metrics, the analysis provides companies with a deeper understanding of their performance and competitive standing. Additionally, the analysis sheds light on the competitiveness of different sectors, including accumulation, fragmentation dominance, and amalgamation traits, offering insights over the base year period studied.

In terms of product offerings, Drug Therapy dominated the market in 2022, capturing a significant market share of 26.70%, closely followed by E-Cigarettes. When considering distribution channels, Hospital Pharmacies led the way in 2022, commanding the largest market share of 32.63%, with Retail Pharmacies following closely behind.

Regionally, Middle East & Africa emerged as a dominant player, claiming the largest market share of 37.70% in 2022, with Asia-Pacific coming next in line.

This comprehensive data-driven analysis underscores the growth trajectory, competitive positioning, and regional dynamics within the rapidly expanding Global Smoking Cessation & Nicotine De-Addiction Product Market.

Report Analysis

• Market Penetration: Provides comprehensive information on the market offered by the key players
• Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
• Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
• Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
• Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
• Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

Market Segment Findings

Market Dynamics

Drivers

• Growing Prevalence of Numerous Diseases due to Smoking Such as Respiratory Disorders and Lung Cancer
• Expanding Market Penetration of De-Addiction Products Globally
• Favorable Government Initiatives to Promote Anti-Smoking Policy and Raising Awareness of the Health Impact due to Smoking

Restraints

• Product Recalls by the Manufacturer and Companies owing to increasing Technical Faults and Stringent Approval Process

Opportunities

• Increasing Approvals and Development of New Nicotine Replacement Products
• Significant Online Market Presence Coupled with Social and Communal Support for Smoking Cessation Products

Challenges

• Side Effects Associated with the Continued Usage of De-Addiction Products Coupled with Rising of Alternatives to Tobacco

Market Trends

• Cumulative Impact of COVID-19
• Cumulative Impact of Russia-Ukraine Conflict
• Cumulative Impact of High Inflation
• Porter's Five Forces Analysis
• Value Chain & Critical Path Analysis
• Regulatory Framework
• Client Customization

Competitive Portfolio

• 22nd Century Group, Inc.
• Alkalon A/S
• Axsome Therapeutics, Inc.
• British American Tobacco PLC
• Cipla Ltd.
• Ditch Labs
• Dr. Reddy's Laboratories Limited
• Enorama Pharma AB
• GlaxoSmithKline PLC
• Imperial Tobacco Company of India Limited
• Itaconix
• Japan Tobacco Inc.
• Johnson & Johnson
• JUUL Labs, Inc.
• NJOY, LLC
• Novartis International AG
• Perrigo Company PLC
• Pfizer Inc.
• Philip Morris International Inc.
• Pierre Fabre S.A.
• Rusan Pharma Ltd.
• Samyang Holdings Corporation
• Sparsha Pharma International Pvt. Ltd.
• Strides Pharma Science Limited
• Takeda Pharmaceutical Co., Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/xziscc

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900